115 Publications items related to 'Burkina Faso'
(Page 1 of 6)
-
Resources: Annual review :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2025
This report outlines the methods used by Malaria Consortium to monitor coverage of the seasonal malaria chemoprevention (SMC) programme and the quality of SMC delivery in 2025.
-
Resources: Annual review :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2025
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for seasonal malaria chemoprevention (SMC) in 2025.
-
Resources: Annual review :
Impact report 2025
We reflect on Malaria Consortium's key achievements in advancing malaria and public health programmes between April 2024 and March 2025 as part of collective efforts that demonstrate the continued…
-
Resources: Poster :
Are we ready for arbovirus threats? Self-assessment of national preparedness in four African countries
Further efforts are needed to enhance surveillance and control measures for Aedes-borne arboviral diseases and develop related policies to boost countries' preparedness for disease outbreaks in…
-
Resources: Poster :
Monitoring the impact of malaria vaccine rollout on awareness, perceptions and coverage of seasonal malaria chemoprevention: Insights from routine programmatic data in Burkina Faso
Introduction of the RTS,S/AS01 malaria vaccine in Burkina Faso did not appear to reduce SMC coverage or caregiver confidence during the 2024 round. Findings indicate both interventions can coexist…
-
Resources: Poster :
Assessing cohort retention and associated factors among seasonal malaria chemoprevention-eligible children in four West and Central African countries in 2024
Child, caregiver and health system factors predict cohort retention. Empowering caregivers through targeted education and community engagement is essential for sustaining seasonal malaria…
-
Resources: Presentation :
Efficacy and safety of intermittent preventive treatment of malaria in school-age children using sulfadoxine-pyrimethamine plus amodiaquine and dihydroartemisinin-piperaquine in rural Burkina Faso
Intermittent preventive treatment of malaria in school-age children was found to be safe, effective at preventing malaria and acceptable in this study.
-
Resources: Presentation :
Estimating the impact of seasonal malaria chemoprevention (SMC) in Burkina Faso: A mathematical modelling framework
This study aims to identify effective methods for monitoring the long-term impact of SMC and the key factors that drive programme effectiveness.
-
Resources: Project report :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2024
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for seasonal malaria chemoprevention (SMC) in 2024.
-
Resources: Project report :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2024
This report outlines the methods used by Malaria Consortium to monitor coverage of the seasonal malaria chemoprevention (SMC) programme and the quality of SMC delivery in 2024.
-
Resources: Presentation :
Estimating the impact of seasonal malaria chemoprevention: A modelling framework using routine data sources in Burkina Faso
Analysis of malaria prevalence data has demonstrated that seasonal malaria chemoprevention is having a significant impact in Burkina Faso.
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2024
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2024.
-
Resources: Journal article :
Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3–59 months in Burkina Faso, Chad and Togo
Caregivers perceived a role model approach to be helpful for improving drug administration during seasonal malaria chemoprevention. Effective promotion via community structures is recommended for…
-
Resources: Journal article :
Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: A qualitative exploration of caregivers and community distributors’ perspectives
In the context of increased adoption of SMC, this paper provides relevant insights and recommendations for the improved implementation of SMC programmes.
-
Resources: Project brief :
Seasonal malaria chemoprevention
Malaria Consortium is a leading implementer of seasonal malaria chemoprevention (SMC) and carries out pioneering research to strengthen the quality and effectiveness of this life-saving intervention.
-
Resources: Poster :
Increasing certainty of seasonal malaria chemoprevention impact: A mathematical model using routine data in Burkina Faso
Age-related variations in routine data can be attributed to other interventions, non-malarial fevers and treatment-seeking, which mask the impact of seasonal malaria chemoprevention.
-
Resources: Capacity statement :
Global capacity statement
Our global capacity statement describes our approach and expertise and provides an overview of the key areas of our work.
-
Resources: Project report :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2023
This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2023.
-
Resources: Project report :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2023
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC in 2023.
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2023
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2023.